1. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC);Brahmer;J IMMUNOTHER CANCER,2018
2. PD-L1 expression in non-small-cell lung cancer including various adenocarcinoma subtypes;Miyazawa;Ann. Thorac. Cardiovasc.,2019
3. Lung cancer biomarkers;Villalobos,2017
4. EMT, cell plasticity and metastasis;Chaffer;CANCER METAST REV,2016
5. MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes;Wu;Cell Commun. Signal. : CCS,2014